Time to administration of stereotactic radiosurgery to the cavity after surgery for brain metastases: a real-world analysis

View More View Less
  • 1 Stich Radiation Oncology,
  • | 2 Department of Neurosurgery,
  • | 3 Division of Biostatistics and Epidemiology, and
  • | 4 Department of Neuropathology, Weill Cornell Medical College/NewYork-Presbyterian Hospital;
  • | 5 Savera Liberty Medical, PC; and
  • | 6 Departments of Otolaryngology and
  • | 7 Neuroscience, Weill Cornell Medical College/NewYork-Presbyterian Hospital, New York, New York
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00
Print or Print + Online

OBJECTIVE

Publications on adjuvant stereotactic radiosurgery (SRS) are largely limited to patients completing SRS within a specified time frame. The authors assessed real-world local recurrence (LR) for all brain metastasis (BM) patients referred for SRS and identified predictors of SRS timing.

METHODS

The authors retrospectively identified BM patients undergoing resection and referred for SRS between 2012 and 2018. Patients were categorized by time to SRS, as follows: 1) ≤ 4 weeks, 2) > 4–8 weeks, 3) > 8 weeks, and 4) never completed. The relationships between timing of SRS and LR, LR-free survival (LRFS), and survival were investigated, as well as predictors of and reasons for specific SRS timing.

RESULTS

In a cohort of 159 patients, the median age at resection was 64.0 years, 56.5% of patients were female, and 57.2% were in recursive partitioning analysis (RPA) class II. The median preoperative tumor diameter was 2.9 cm, and gross-total resection was achieved in 83.0% of patients. All patients were referred for SRS, but 20 (12.6%) did not receive it. The LR rate was 22.6%, and the time to SRS was correlated with the LR rate: 2.3% for patients receiving SRS at ≤ 4 weeks postoperatively, 14.5% for SRS at > 4–8 weeks (p = 0.03), and 48.5% for SRS at > 8 weeks (p < 0.001). No LR difference was seen between patients whose SRS was delayed by > 8 weeks and those who never completed SRS (48.5% vs 50.0%; p = 0.91). A similar relationship emerged between time to SRS and LRFS (p < 0.01). Non–small cell lung cancer pathology (p = 0.04), earlier year of treatment (p < 0.01), and interval from brain MRI to SRS (p < 0.01) were associated with longer intervals to SRS. The rates of receipt of systemic therapy also differed significantly between patients by category of time to SRS (p = 0.02). The most common reasons for intervals of > 4–8 weeks were logistic, whereas longer delays or no SRS were caused by management of systemic disease or comorbidities.

CONCLUSIONS

Available data on LR rates after adjuvant SRS are often obtained from carefully preselected patients receiving timely treatment, whereas significantly less information is available on the efficacy of adjuvant SRS in patients treated under “real-world” conditions. Management of these patients may merit reconsideration, particularly when SRS is not delivered within ≤ 4 weeks of resection. The results of this study indicate that a substantial number of patients referred for SRS either never receive it or are treated > 8 weeks postoperatively, at which time the SRS-treated patients have an LR risk equivalent to that of patients who never received SRS. Increased attention to the reasons for prolonged intervals from surgery to SRS and strategies for reducing them is needed to optimize treatment. For patients likely to experience delays, other radiotherapy techniques may be considered.

ABBREVIATIONS

BM = brain metastasis; EMR = electronic medical record; GTR = gross-total resection; KPS = Karnofsky Performance Status; LC = local control; LR = local recurrence; LRFS = LR-free survival; NSCLC = non–small cell lung cancer; OS = overall survival; PS = performance status; RPA = recursive partitioning analysis; RT = radiotherapy; SRS = stereotactic radiosurgery; WBRT = whole-brain RT.

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00

Contributor Notes

Correspondence Theodore H. Schwartz: Weill Cornell Medical College/NewYork-Presbyterian Hospital, New York, NY. schwarh@med.cornell.edu.

INCLUDE WHEN CITING Published online May 28, 2021; DOI: 10.3171/2020.10.JNS201934.

Disclosures The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.

  • 1

    Patchell RA, Tibbs PA, Walsh JW, et al. . A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med. 1990;322(8):494500.

    • Search Google Scholar
    • Export Citation
  • 2

    Patchell RA, Tibbs PA, Regine WF, et al. . Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA. 1998;280(17):14851489.

    • Search Google Scholar
    • Export Citation
  • 3

    Kocher M, Soffietti R, Abacioglu U, et al. . Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol. 2011;29(2):134141.

    • Search Google Scholar
    • Export Citation
  • 4

    Chow E, Davis L, Holden L, et al. . Prospective assessment of patient-rated symptoms following whole brain radiotherapy for brain metastases. J Pain Symptom Manage. 2005;30(1):1823.

    • Search Google Scholar
    • Export Citation
  • 5

    Li J, Bentzen SM, Li J, et al. . Relationship between neurocognitive function and quality of life after whole-brain radiotherapy in patients with brain metastasis. Int J Radiat Oncol Biol Phys. 2008;71(1):6470.

    • Search Google Scholar
    • Export Citation
  • 6

    Chang EL, Wefel JS, Hess KR, et al. . Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol. 2009;10(11):10371044.

    • Search Google Scholar
    • Export Citation
  • 7

    Steinmann D, Paelecke-Habermann Y, Geinitz H, et al. . Prospective evaluation of quality of life effects in patients undergoing palliative radiotherapy for brain metastases. BMC Cancer. 2012;12:283.

    • Search Google Scholar
    • Export Citation
  • 8

    Soffietti R, Kocher M, Abacioglu UM, et al. . A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. J Clin Oncol. 2013;31(1):6572.

    • Search Google Scholar
    • Export Citation
  • 9

    Jensen CA, Chan MD, McCoy TP, et al. . Cavity-directed radiosurgery as adjuvant therapy after resection of a brain metastasis. J Neurosurg. 2011;114(6):15851591.

    • Search Google Scholar
    • Export Citation
  • 10

    Hartford AC, Paravati AJ, Spire WJ, et al. . Postoperative stereotactic radiosurgery without whole-brain radiation therapy for brain metastases: potential role of preoperative tumor size. Int J Radiat Oncol Biol Phys. 2013;85(3):650655.

    • Search Google Scholar
    • Export Citation
  • 11

    Brennan C, Yang TJ, Hilden P, et al. . A phase 2 trial of stereotactic radiosurgery boost after surgical resection for brain metastases. Int J Radiat Oncol Biol Phys. 2014;88(1):130136.

    • Search Google Scholar
    • Export Citation
  • 12

    Mahajan A, Ahmed S, Li J, et al. . Postoperative stereotactic radiosurgery versus observation for completely resected brain metastases: results of a prospective randomized study. Int J Radiat Oncol Biol Phys. 2016;96(2 Suppl):S2.

    • Search Google Scholar
    • Export Citation
  • 13

    Mahajan A, Ahmed S, McAleer MF, et al. . Prospective randomized trial of post-operative stereotactic radiosurgery versus observation for completely resected brain metastases. Lancet Oncol. 2017;18(8):10401048.

    • Search Google Scholar
    • Export Citation
  • 14

    Brown PD, Ballman KV, Cerhan JH, et al. . Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial. Lancet Oncol. 2017;18(8):10491060.

    • Search Google Scholar
    • Export Citation
  • 15

    Shi S, Sandhu N, Jin MC, et al. . Stereotactic radiosurgery for resected brain metastases: single-institutional experience of over 500 cavities. Int J Radiat Oncol Biol Phys. 2020;106(4):764771.

    • Search Google Scholar
    • Export Citation
  • 16

    Dormand EL, Banwell PE, Goodacre TE. Radiotherapy and wound healing. Int Wound J. 2005;2(2):112127.

  • 17

    Wang J, Boerma M, Fu Q, Hauer-Jensen M. Radiation responses in skin and connective tissues: effect on wound healing and surgical outcome. Hernia. 2006;10(6):502506.

    • Search Google Scholar
    • Export Citation
  • 18

    Patel DM, Agarwal N, Tomei KL, et al. . Optimal timing of whole-brain radiation therapy following craniotomy for cerebral malignancies. World Neurosurg. 2015;84(2):412419.

    • Search Google Scholar
    • Export Citation
  • 19

    Jarvis LA, Simmons NE, Bellerive M, et al. . Tumor bed dynamics after surgical resection of brain metastases: implications for postoperative radiosurgery. Int J Radiat Oncol Biol Phys. 2012;84(4):943948.

    • Search Google Scholar
    • Export Citation
  • 20

    Atalar B, Choi CY, Harsh GR IV, et al. . Cavity volume dynamics after resection of brain metastases and timing of postresection cavity stereotactic radiosurgery. Neurosurgery. 2013;72(2):180185.

    • Search Google Scholar
    • Export Citation
  • 21

    Patel RA, Lock D, Helenowski IB, et al. . Postsurgical cavity evolution after brain metastasis resection: how soon should postoperative radiosurgery follow? World Neurosurg. 2018;110:e310e314.

    • Search Google Scholar
    • Export Citation
  • 22

    Shah JK, Potts MB, Sneed PK, et al. . Surgical cavity constriction and local progression between resection and adjuvant radiosurgery for brain metastases. Cureus. 2016;8(4):e575.

    • Search Google Scholar
    • Export Citation
  • 23

    McPherson CM, Suki D, Feiz-Erfan I, et al. . Adjuvant whole-brain radiation therapy after surgical resection of single brain metastases. Neuro Oncol. 2010;12(7):711719.

    • Search Google Scholar
    • Export Citation
  • 24

    Benedict SH, Yenice KM, Followill D, et al. . Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys. 2010;37(8):40784101.

    • Search Google Scholar
    • Export Citation
  • 25

    Choi CYH, Chang SD, Gibbs IC, et al. . Stereotactic radiosurgery of the postoperative resection cavity for brain metastases: prospective evaluation of target margin on tumor control. Int J Radiat Oncol Biol Phys. 2012;84(2):336342.

    • Search Google Scholar
    • Export Citation
  • 26

    Iorio-Morin C, Masson-Côté L, Ezahr Y, et al. . Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control. J Neurosurg. 2014;121(suppl):6974.

    • Search Google Scholar
    • Export Citation
  • 27

    Strauss I, Corn BW, Krishna V, et al. . Patterns of failure after stereotactic radiosurgery of the resection cavity following surgical removal of brain metastases. World Neurosurg. 2015;84(6):18251831.

    • Search Google Scholar
    • Export Citation
  • 28

    McDermott MW, Cosgrove GR, Larson DA, et al. . Interstitial brachytherapy for intracranial metastases. Neurosurg Clin N Am. 1996;7(3):485495.

    • Search Google Scholar
    • Export Citation
  • 29

    Schulder M, Black PML, Shrieve DC, et al. . Permanent low-activity iodine-125 implants for cerebral metastases. J Neurooncol. 1997;33(3):213221.

    • Search Google Scholar
    • Export Citation
  • 30

    Rogers LR, Rock JP, Sills AK, et al. . Results of a phase II trial of the GliaSite radiation therapy system for the treatment of newly diagnosed, resected single brain metastases. J Neurosurg. 2006;105(3):375384.

    • Search Google Scholar
    • Export Citation
  • 31

    Dagnew E, Kanski J, McDermott MW, et al. . Management of newly diagnosed single brain metastasis using resection and permanent iodine-125 seeds without initial whole-brain radiotherapy: a two-institution experience. Neurosurg Focus. 2007;22(3):E3.

    • Search Google Scholar
    • Export Citation
  • 32

    Huang K, Sneed PK, Kunwar S, et al. . Surgical resection and permanent iodine-125 brachytherapy for brain metastases. J Neurooncol. 2009;91(1):8393.

    • Search Google Scholar
    • Export Citation
  • 33

    Petr MJ, McPherson CM, Breneman JC, Warnick RE. Management of newly diagnosed single brain metastasis with surgical resection and permanent I-125 seeds without upfront whole brain radiotherapy. J Neurooncol. 2009;92(3):393400.

    • Search Google Scholar
    • Export Citation
  • 34

    Ruge MI, Suchorska B, Maarouf M, et al. . Stereotactic 125iodine brachytherapy for the treatment of singular brain metastases: closing a gap?. Neurosurgery. 2011;68(5):12091219.

    • Search Google Scholar
    • Export Citation
  • 35

    Ruge MI, Kocher M, Maarouf M, et al. . Comparison of stereotactic brachytherapy (125iodine seeds) with stereotactic radiosurgery (LINAC) for the treatment of singular cerebral metastases. Strahlenther Onkol. 2011;187(1):714.

    • Search Google Scholar
    • Export Citation
  • 36

    Wernicke AG, Yondorf MZ, Peng L, et al. . Phase I/II study of resection and intraoperative cesium-131 radioisotope brachytherapy in patients with newly diagnosed brain metastases. J Neurosurg. 2014;121(2):338348.

    • Search Google Scholar
    • Export Citation
  • 37

    Pham A, Yondorf MZ, Parashar B, et al. . Neurocognitive function and quality of life in patients with newly diagnosed brain metastasis after treatment with intra-operative cesium-131 brachytherapy: a prospective trial. J Neurooncol. 2016;127(1):6371.

    • Search Google Scholar
    • Export Citation
  • 38

    Raleigh DR, Seymour ZA, Tomlin B, et al. . Resection and brain brachytherapy with permanent iodine-125 sources for brain metastasis. J Neurosurg. 2017;126(6):17491755.

    • Search Google Scholar
    • Export Citation
  • 39

    Wernicke AG, Hirschfeld CB, Smith AW, et al. . Clinical outcomes of large brain metastases treated with neurosurgical resection and intraoperative cesium-131 brachytherapy: results of a prospective trial. Int J Radiat Oncol Biol Phys. 2017;98(5):10591068.

    • Search Google Scholar
    • Export Citation
  • 40

    Julie DA, Lazow SP, Vanderbilt DB, et al. . A matched-pair analysis of clinical outcomes after intracavitary cesium-131 brachytherapy versus stereotactic radiosurgery for resected brain metastases. J Neurosurg. 2021;134(5):14471454.

    • Search Google Scholar
    • Export Citation
  • 41

    Asher AL, Burri SH, Wiggins WF, et al. . A new treatment paradigm: neoadjuvant radiosurgery before surgical resection of brain metastases with analysis of local tumor recurrence. Int J Radiat Oncol Biol Phys. 2014;88(4):899906.

    • Search Google Scholar
    • Export Citation
  • 42

    Patel KR, Burri SH, Asher AL, et al. . Comparing preoperative with postoperative stereotactic radiosurgery for resectable brain metastases: a multi-institutional analysis. Neurosurgery. 2016;79(2):279285.

    • Search Google Scholar
    • Export Citation
  • 43

    Patel KR, Burri SH, Boselli D, et al. . Comparing pre-operative stereotactic radiosurgery (SRS) to post-operative whole brain radiation therapy (WBRT) for resectable brain metastases: a multi-institutional analysis. J Neurooncol. 2017;131(3):611618.

    • Search Google Scholar
    • Export Citation
  • 44

    Prabhu R, Shu HK, Hadjipanayis C, et al. . Current dosing paradigm for stereotactic radiosurgery alone after surgical resection of brain metastases needs to be optimized for improved local control. Int J Radiat Oncol Biol Phys. 2012;83(1):e61e66.

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 629 629 629
Full Text Views 90 90 90
PDF Downloads 123 123 123
EPUB Downloads 0 0 0